Novel Clinical Target in Fragile X Syndrome

Condition:   Fragile X Syndrome (FXS) Intervention:   Drug: 18F-FTC-146 Sponsor:   Stanford University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials